Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-menthol preparation NPO-11
- Development stage
- Phase 3
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Administration
- Topical (spray Onto Gastric Mucosa)
01
Overview
L-menthol preparation NPO-11 is a pharmaceutical formulation containing L-menthol, developed for its potential anti-peristaltic activity. When sprayed directly onto the gastric mucosa, it relaxes gastrointestinal smooth muscle, leading to suppression of gastric peristalsis. This effect is particularly beneficial during upper gastrointestinal (GI) endoscopic procedures by improving visualization and access through reduced movement of the stomach lining[1][2].
- Other names
- L-menthol preparation NPO-11
02
Targets
LTCC (Voltage-gated calcium channel (L-type))
Beyond the preview
Go deeper on L-menthol preparation NPO-11.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L-menthol preparation NPO-11.